Molecular Testing

You are here

Molecular Testing

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

2020 TTF AM SESSION - RAEZ - Agnostic Tumor Therapy - The Future of Lung Cancer Has Arrived
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Molecular Testing, Targeted Therapy
2020 TTF WEST AM Session - Challenges in Molecular Diagnosis: The Need to Do More Testing
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Molecular Testing
ASCO Lung Cancer Roundtable - NSCLC - New Potential Treatments for MET and RET Positive NSCLC
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Biopsy/Tissue Collection, Adjuvant Therapy, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Molecular Testing, Non Small Cell Lung Cancer, Clinical Trials, Investigational Agents
ASCO Lung Cancer Roundtable - NSCLC - Enhertu and the Potential for Treatment of HER2 Positive NSCLC
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Clinical Trials, Investigational Agents, Biopsy/Tissue Collection, Targeted Therapy, Molecular Testing, Non Small Cell Lung Cancer
RET/MET/BRAF: initial treatment, acquired resistance, Q&A Joshua Sabari, MD Joshua Bauml, MD
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired...
Cancer Journey:
In Treatment, In Remission
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Molecular Testing, Targeted Therapy, Tumor Marker Tests

Articles

Lilly and GRACE Partnership
GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests. We are happy to...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Chemo Medication, Immunotherapies, Chemotherapy, Non Small Cell Lung Cancer, Biopsy/Tissue Collection, Targeted Therapy, Molecular Testing
Translation of Molecular Genetics in Lung Cancer into Treatment Decision
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Molecular Testing, General Lung Cancer
What is the Role of Molecular Marker Testing in the Adjuvant or Post-Op Setting?
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and targeted therapy in the adjuvant or post-operative setting.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Molecular Testing, Adjuvant Therapy, Targeted Therapy
Access & Assistance for ALK+, ROS1 & EGFR Patients
Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted therapies.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Procedures & Treatments, Molecular Testing, Biopsy/Tissue Collection, Scans - PET-CT, etc.
Panel Q&A Session on Acquired Resistance with Drs. Riely & Horn
Dr. West moderates a question & answer session with Drs. Leora Horn and Greg Riely on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Molecular Testing

Community Forum

9/12/2020 online Targeted Therapies Patient Forum
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Targeted Therapy, Molecular Testing, First-line treatment, Non Small Cell Lung Cancer, Targeted Therapies Blood
Progression on Tarceva - T790m negative
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Molecular Testing, Immunotherapies, Non Small Cell Lung Cancer